| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PARDES BIOSCIENCES, INC. | Chief Scientific Officer | Stock Option (Right to Buy) | 100,000 | 01 Feb 2022 | Direct | ||
| AETHLON MEDICAL INC | Chief Scientific Officer | Employee Stock Option (Right to Buy) | 60,620 | 01 Feb 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AEMD | AETHLON MEDICAL INC | 01 Feb 2023 | 1 | $0 | 4 | Chief Scientific Officer | 02 Feb 2023, 15:14 |
| AEMD | AETHLON MEDICAL INC | 01 Feb 2023 | 0 | $0 | 3 | Chief Scientific Officer | 02 Feb 2023, 15:08 |
| /report/000089924322004214-arnold-lee-d-2022-02-01 | PARDES BIOSCIENCES, INC. | 01 Feb 2022 | 1 | $0 | 4 | Chief Scientific Officer | 02 Feb 2022, 18:04 |
| /report/000089924321049792-arnold-lee-d-2021-12-23 | PARDES BIOSCIENCES, INC. | 23 Dec 2021 | 0 | $0 | 3 | Chief Scientific Officer | 27 Dec 2021, 16:23 |